SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 12:36 pm Sale |
2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 0 0.000% |
-2,230,250 (Position Closed) |
Filing |
| 2021-11-29 4:39 pm Purchase |
2021-11-18 | 13G | Bolt Biotherapeutics, Inc. BOLT |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,230,250 6.000% |
2,230,250 (New Position) |
Filing |